Home > For doctors > Protocols> Endocrine > Diabetes

Search

Diabetes mellitus
Erectile dysfunction management options

Oral treatment

Sildenafil 

This is an oral phosphodiasterase inhibitor suitable for treatment of Erectile Dysfunction in diabetic patients.

It is likely to be considered first line in most patients. Absolute contraindications are listed below and guidelines on its use in diabetic patients with known IHD or with known risk factors for IHD. It should be remembered that silent ischaemia occurs in a substantial proportion of diabetic men so that cardiovascular risk factors should be assessed and applied to the graded risk management algorithm.

Contraindications

Dosage

Guidelines for Sildenafil use in Diabetic patients 

Assessment of Cardiovascular Risk and suitability for OP treatment of Erectile Dysfunction with Sildenafil. Taken from a Consensus Statement J.Clin Practice, Vol 53, No. 6 1999.

  1. If patient has known cardiovascular disease
  2. If patient has no history of cardiovascular disease

Intraurethral preparations

MUSE (Medical Urethral System for Erection) 

PGE1, delivered in pellet form into the urethra.

Administration instructions 

This is preferably taught by a specialist. An instruction video is also available.

Side Effects

Avoid use in patients whose partners are pregnant.

Intracorporial injection 

PGE1 Caverject Viridal

Teaching a patient to self-inject

This should be supervised by a Consultant Diabetologist, Erectile Dysfunction Nurse or Urologist.

Recommended test dose of PGE1

Consider combination with Papaverine or Phentolamine if 40mcg fails.

NOTE: Injection should be given no more than 3 times per week or once every 2 days.

Side Effects

Vacuum erection devices

Surgery

Indications 

Refer for assessment by Consultant Urologist


Source: Northumbria NHS Health Care Trust diabetes protocol